Carbachol
- Generic Name
- Carbachol
- Brand Names
- Carbastat, Miostat
- Drug Type
- Small Molecule
- Chemical Formula
- C6H15N2O2
- CAS Number
- 462-58-8
- Unique Ingredient Identifier
- 54Z8M50D6Q
Overview
Carbamoylcholine, also known as carbachol, is a muscarinic agonist discovered in 1932. Carbamoylcholine was initially used as a treatment for migraines, induction of diuresis, and other parasympathetic effects. Carbamoylcholine was granted FDA approval on 28 September 1972.
Background
Carbamoylcholine, also known as carbachol, is a muscarinic agonist discovered in 1932. Carbamoylcholine was initially used as a treatment for migraines, induction of diuresis, and other parasympathetic effects. Carbamoylcholine was granted FDA approval on 28 September 1972.
Indication
Carbamoylcholine is indicated to induce miosis for surgery and to reduce intraocular pressure elevations in the first 24 hours after cataract surgery.
Associated Conditions
- Acute angle-closure glaucoma
- Increased Intra Ocular Pressure (IOP)
- Open Angle Glaucoma (OAG)
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.